Clinical Trial Update: Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating sorafenib to overcome resistance to systemic chemotherapy in androgen-independent (castration-resistant) prostate cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Oncology Specialists, S.C. | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-07